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S U M M A R Y
Strongyloides stercoralis is a ubiquitous intestinal nematode, endemic in tropical and subtropical areas,
with an unusual life cycle in which autoinfection can take place. In the immunosuppressed host,
autoinfection is accelerated and larvae can spread in all organs, leading to hyperinfection syndrome or to
disseminated disease. Strongyloidiasis is presently rare in Western Countries, often with delayed
diagnosis due to a lack of clinical suspicion, nonspeciﬁc presentation, and low parasite intestinal output.
Foreign HIV-infected patients from endemic areas are at increased risk of severe disease caused by this
parasite. Here we report the case of a patient with disseminated lethal disease, whose disseminated state
was missed 2 years prior to the current presentation. This emblematic case shows that intestinal
parasitic infections, highly prevalent in Sub-Saharan Africa, Southeast Asia, and Latin America, are
difﬁcult to recognize but should be thoroughly investigated and excluded in high-risk patients, to
prevent severe long-term lethal sequelae.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Strongyloidiasis is an emerging global infection that is under-
estimated in many countries1. The nematode Strongyloides
stercoralis, causative agent of strongyloidiasis, is an opportunistic
intestinal threadworm parasite that infects man, cats, dogs and can
be passed from man to dogs or cats or vice versa1. Ground soil is the
primary source of the nematode, where it is found in two forms, the
adult worm and the larva: ﬁlariform larvae produced by adults can
penetrate the intact skin after contact with contaminated soil1.
Strongyloidiasis is endemic in tropical, subtropical and
temperate regions, affecting 30-100 million people overall1.
Immunocompromised individuals, particularly HIV-infected peo-
ple, are the most vulnerable population at risk for developing life-
threatening clinical syndromes, such as Hyperinfection Syndrome
(HS) and dissemination2. In these hosts, autoinfection is acceler-
ated and larvae can reach different organs: when migration is
conﬁned to respiratory and gastrointestinal systems, the picture is
known as HS; disseminated infection occurs when involvement of
other organs is present, with mortality rates as high as 80%1. Here* Corresponding author. Tel.: +39 085 4252410; fax: +39 085 4252499.
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http://dx.doi.org/10.1016/j.ijid.2012.11.031we report on a case of disseminated lethal disease whose
disseminated state was missed 2 years in advance.
2. Case report
A 33-year-old Nigerian male, who had been living in Italy since
2003, was ﬁrst hospitalized in February 2008 due to fever, multiple
lung inﬁltrates, severe hepatic cholestasis, peripheral and bone
marrow hypereosinophilia, and enlarged axillary lymph nodes
(7 cm in diameter in the right axilla). An HIV infection (clade
CRF02_AG) was diagnosed, with 210 000 copies/ml and 350 CD4 T
cells/mm3. Genotype resistance testing (GRT) showed the following
pattern: I13 V, K20I, M36I, L63P, H69K, and L89 M. Furthermore,
hypergammaglobulinemia and high-level peripheral Epstein–Barr
virus (EBV) replication (1503 copies/ml) were detected, and a liver
biopsy revealed high loads of both cytomegalovirus (CMV) DNA
(3616 copies/mg) and EBV DNA (2072 copies/mg). During his
hospitalization, eosinophil counts reached 600 cells/mm3 (11.1%),
rising to 1900 cells/mm3 (19.4%) after 15 days. A chest computed
tomography (CT) scan showed the presence of parenchymal
thickening on the anterior segment of the right upper lobe, other
circumscribed areas of thickening in the posterior segment of the
same lobe, and the presence of lymph nodes in the axilla bilaterally.
He was treated with clarithromycin, ceftriaxone, co-trimoxazole,
meropenem, and antiretroviral therapy. A histological lymph nodeses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Detection of Strongyloides stercoralis in a gastric biopsy specimen: larvae and eggs in the gastric crypts; hematoxylin–eosin 400.
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adenitis; PCR ampliﬁcations ruled out mycobacterial infections,
human herpesvirus type 6 (HHV6), HHV8, varicella zoster virus
(VZV), and Toxoplasma. Parasitological examinations of stools were
repeatedly negative. Long-term corticosteroids, antiviral therapy
(ganciclovir), and antiretroviral therapy with tenofovir/emtricita-
bine, darunavir, and ritonavir were rapidly beneﬁcial. However the
patient interrupted all treatments at 3 months after discharge and
disappeared.
In August 2010, he was re-hospitalized due to fever and a
lethargic state with nuchal rigidity. Early investigations showed
remarkable elevations of C-reactive protein, ﬁbrinogen, D-dimer,
ammonium, transaminases, alkaline phosphatase, and gamma-
glutamyl transpeptidase.
At this time, there was no evidence of peripheral eosinophilia.
On admission, the CD4 T cell count was 105 cells/mm3, HIV RNA
was 2170 copies/ml, and a cerebrospinal ﬂuid (CSF) examination
revealed high polymorphonuclear cell counts (85%, >1000/ml),
high glucose, and low protein levels (1.8 mg/dl). CSF culture grew
Enterococcus faecalis, while blood and urine cultures were negative.
Intestinal sub-occlusion ensued, with persistent stomach ache. An
X-ray of the abdomen and CT scans were unremarkable. Upper
gastrointestinal tract endoscopy showed diffuse and severe
inﬂammatory lesions in the esophageal and gastric mucous
membranes. Cytological examinations of esophageal specimens
revealed the presence of fungal hyphae and spores consistent with
Candida albicans, with a positive culture for C. albicans on mouth
swabs. Histological evaluation of gastric biopsies disclosed the
presence of Strongyloides stercoralis (Figure 1). Repeated stool
examinations revealed rhabditiform larvae of S. stercoralis.
Serological assays (Immunoﬂuorescent assay test, IFAT) for speciﬁc
antibodies were negative. High-level peripheral CMV replication
(58 850 copies/ml) was detected. In spite of treatment with oral
ivermectin (200 mg/kg of body weight daily), the patient died a few
days later due to progressive encephalopathy. Permission was not
granted for an autopsy.
3. Discussion
In HIV-infected patients, the prevalence of Strongyloides
infections is higher than the general population2. A study in
2009 showed that in the African population rates of infection with
Strongyloides may be as high as 12.6%, in comparison with 0.6% of
HIV negative subjects3. In these patients, factors that determine
the occurrence of dissemination of S. stercoralis are not fully
known. A ﬁne equilibrium between T helper (Th1) and T helper 2
(Th2) response may play a key role2.
Immune responses elicited by nematode infection in normal
subjects are Th2 type, with high levels of IL-3, IL-4, IL-5, IL-13,
eosinophils and speciﬁc IgA2. It has been suggested that B
lymphocytes are essential for the acquisition of resistance tolarval S. stercoralis, together with eosinophils, that are believed to
function as antigen presenting cells for the induction of the
primary and secondary Th2 immune response to S. stercoralis2.
During early phases of his disease, the patient experienced vague
symptoms such as fever, nausea and weight loss, with laboratory
ﬁndings of hypereosinophilia and increased serum IgE concentra-
tions4. Progressive Strongyloidiasis has been associated with a high
incidence of bacterial or yeast infections and sepsis with
meningitis due to Enterococcus faecalis signaled clinical evolution
in our case. The postulated mechanism in such cases is
transmission of enteric bacteria through the bowel wall by
invading ﬁlariform larvae5. Unfortunately, the disease is largely
unrecognized both in the uncomplicated and in the complicated
cases, mainly due to the low level of clinical suspicion and to the
low sensitivity of diagnostic tools. Several diagnostic methods
have been compared to detect the presence of S. stercoralis,
including stool examination, stool culture on a blood agar plate,
enzyme-linked immunosorbent assay (ELISA), serum indirect
ﬂuorescent antibody test, PCR and gastrointestinal aspirate or
biopsy4. However, all these techniques, frequently not feasible,
provide results with low sensitivity and speciﬁcity4. As the case
reported shows, the major clinical problem often lies in timely and
effective recognition and treatment of patients, especially if they
are immunocompromised and from endemic areas. The present
case clearly underline the need to suspect un underlying
gastrointestinal helminthic disease when Enterococcal meningitis
is diagnosed in an at-risk patient. In this case, neither Enterococcal
meningitis, nor eosinophilia in the early stages helped to prevent
this missed diagnosis, due to persistent lack of clinical suspicion.
The concurrent ﬁndings of high-load CMV-DNA and EBV-DNA on
liver biopsy specimens and severe lymphoadenopathies contrib-
uted to divert from the right diagnostic suspicion, together with
repeatedly negative parasitological examination of stools, in spite
of the suggestive geographical origin of our patient. As gastroin-
testinal and meningeal symptoms set the stage of his clinical
picture at his second in-hospital presentation, histological
diagnosis of strongyloidiasis came from gastric biopsies, per-
formed due to persistent gastric pain and intestinal sub-occlusion.
The examination of multiple sections revealed a patchy distribu-
tion of the parasite. Sequential stool examinations, on purpose
requested, revealed rhabditiform larvae of S. stercoralis on
multiple specimens. According to many authors, there is no
general agreement on the optimal diagnostic strategy for
Strongyloides stercoralis infection, as well as laboratory ﬁndings
are usually nonspeciﬁc, the method of parasite detection in a single
specimen has very low sensitivity1. ELISA tests for antibodies may
provide a high sensitivity (83-93%) and speciﬁcity (95-98%), but
the presence of antibodies does not distinguish between past and
current infection4. The examination of gastrointestinal specimens
for larvae has been shown to be the most sensitive diagnostic
procedure for S. stercoralis, with a false-negative frequency less
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strongyloidiasis in HIV-infected subjects. Helminthic infections, in
particular strongyloidiasis, should be suspected when unexplained
pulmonary and/or gastrointestinal symptoms occur in immuno-
compromised patients from endemic areas. Given the increasing
number of immunocompromised individuals worldwide and the
greater diffusion of migration ﬂows, clinicians need to realize that
risk factors for this neglected helminthic disease should be
considered early in the management of even in complex clinical
pictures, as timely treatment of the parasite may lead to higher
rates of successful resolution.
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